Int'l Business Department, Concord Pharmaceuticals Ltd.
- Home
- Bangladesh
- Sonargaon
- Int'l Business Department, Concord Pharmaceuticals Ltd.
Concord Pharmaceuticals Limited (CPL), a leading human medicine manufacturer in Bangladesh.
Address
Sima Blossom (11th Floor) House# 3 (New), 390 (Old), Road# 16 (New), 27 (Old), Dhanmondi
Sonargaon
1209
Telephone
Website
Alerts
Be the first to know and let us send you an email when Int'l Business Department, Concord Pharmaceuticals Ltd. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Contact The Practice
Send a message to Int'l Business Department, Concord Pharmaceuticals Ltd.:
Shortcuts
Category
Concord Pharmaceuticals Limited
Concord Pharmaceuticals Limited (CPL), a leading human medicine manufacturer in Bangladesh. We always thrive to introduce top notch quality human medicine for the health & wellbeing of the nation worldwide. With the philosophy “Better medicine Better life…” CPL has started its export journey since 2015. Hence its efforts to improve quality never ends up. We continuously sets next level of standards and feels passionate to achieve all that. All the manufacturing processes are followed by ISO 9001:2015 & WHO-GMP guidelines to produce quality products.
CPL has 112 dosage form of different therapeutic classes like Antibiotics, Antiviral, Antidiabetics, Anti-Ulcerants, Analgesics & Antipyretics, Antihistamine, Antidepressant, Cardiovascular, Vitamins & minerals, NSAIDs etc.
Presently CPL products are exporting to Bhutan, Cambodia, Myanmar, Sri Lanka, Vietnam, Thailand, Liberia, Yemen and Congo now. During this marvelous journey the company has achieved accreditation from Ministry of Health, Cambodia and currently holds the Yemen GMP certificate.
We’ve consistently been recognized in the international arena for our exceptional outcomes and service for worldwide wholesalers, government agencies, major importers, chain of drug stores, contract manufacturing and relief organizations. We are concerned to tie-up with new business partners and we welcome prospective agents for our medicines.